Windels Marx Lane Mittendorf

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Cases114
Challenger50%
Patent Owner50%
NPE50%
windels-marx
windelsmarx.com
Practice Areas
BiotechCommunicationsTransport., E-Comm.
Top Attorneys
Patrick J. CoyneNeal S. CohenPeter Kinsella
Elite Ratings
DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
A

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered
Case
Description
10/29/24
Allergan Inc v. Mankind Pharma Ltd
1:23-CV-00272
 (
D. DE
)
FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,851,504. (vfm) (Entered: 10/29/2024)
10/29/24
Allergan Inc v. Mankind Pharma Ltd
1:23-CV-00272
 (
D. DE
)
SO ORDERED D.I. [134] Stipulation of Dismissal filed by Allergan, Inc., AbbVie Inc.. ***Civil Case Terminated. Ordered by Judge John F. Murphy on 10/29/2024. (vfm) (Entered: 10/29/2024)
10/29/24
Allergan Inc v. Mankind Pharma Ltd
1:23-CV-00272
 (
D. DE
)
STIPULATION of Dismissal by AbbVie Inc., Allergan, Inc.. (Tigan, Jeremy) (Entered: 10/29/2024)
10/09/24
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
1:20-MD-02930
 (
D. DE
)
UNSECURED Bond for Injunction Pending Appeal, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 10/9/2024 (nms). (Entered: 10/09/2024)
10/08/24
In re: Xarelto (Rivaroxaban) ('310) Patent Litigation
1:21-MD-03017
 (
D. DE
)
STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 10/8/2024 (nms). (Entered: 10/08/2024)
10/08/24
In re: Xarelto (Rivaroxaban) ('310) Patent Litigation
1:21-MD-03017
 (
D. DE
)
SO ORDERED, re [316] STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 10/23/2024). Signed by Judge Richard G. Andrews on 10/8/2024. (nms) (Entered: 10/08/2024)
10/04/24
Abbvie Inc v. DR Reddys Laboratories Ltd
1:20-CV-00968
 (
D. DE
)
Joint STIPULATION of Infringement and Proposed Order Regarding U.S. Patent Nos. 11,110,.087 and 11,369,599 by AbbVie Inc., Genentech, Inc.. (Streifthau-Livizos, Michelle) (Entered: 10/04/2024)
10/04/24
Abbvie Inc v. DR Reddys Laboratories Ltd
1:20-CV-00968
 (
D. DE
)
Joint STIPULATION Amended Scheduling Order by AbbVie Inc., Genentech, Inc.. (Streifthau-Livizos, Michelle) (Entered: 10/04/2024)
09/16/24
Abbvie Inc v. Alkem Laboratories Ltd
1:22-CV-01423
 (
D. DE
)
SO ORDERED, re [273] Stipulation and Order to Extend Expert Reports and Daubert Motions Deadlines. (*Reset Scheduling Order Deadlines: Opening Expert Reports due by 11/14/2024; Rebuttal Expert Reports due by 1/23/2025; Reply Expert Reports due by 2/14/2025; Close of Expert Discovery on 4/10/2025; Daubert Motions due by 4/17/2025). Signed by Judge Jennifer L. Hall on 9/16/2024. (ceg) (Entered: 09/16/2024)
09/09/24
American Regent Inc v. Eugia Pharma Specialities Ltd
2:24-CV-08956
 (
D. NJ
)
NOTICE of Appearance by DMITRY V. SHELHOFF on behalf of All Defendants (SHELHOFF, DMITRY) (Entered: 09/09/2024)